Dementia Discovery Fund
Biotech Investor · 6 portfolio companies
Portfolio
6
Combined Value
$229.8M
Focus Areas
8
Top Stage
preclinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Alector | $229.8M |
| Convexia | — |
| Vima Therapeutics | — |
| Augustine Therapeutics | — |
| Gen2 Neuroscience | — |
| Callio Therapeutics | — |